Cotcha Yankinov
Bluelight Crew
- Joined
- Jul 21, 2015
- Messages
- 2,952
The study indicates a low increase of DOPAC increase with Mirtazapine in the striatum, which is saying lower NE related effects with Mirtazapine for striatum, but similar NE levels elsewhere apparently. It could be that Mianserin doesn't effect NE in the striatum either but seeing as they didn't mention that, they were probably implying that that was an abnormality specific to mirtazapine.
The lack of serotonergic effects with mianserin could possibly be due to NRI and/or differential affinity for a2a vs. a2c presynaptic receptors with differential expression of a2a and a2c across cell types.
For example, what if Mianserin had higher affinity for a2a which was more predominantly expressed on NE neurons compared to mirtazapine which might have lower (relative to Mianserin) affinity for a2a and higher affinity for a2c which could be expressed more so on serotonergic neurons? Just conjecture though.
And I can't recall where I remembered that study from, was probably searching for more about the a2 autoreceptors.
The lack of serotonergic effects with mianserin could possibly be due to NRI and/or differential affinity for a2a vs. a2c presynaptic receptors with differential expression of a2a and a2c across cell types.
For example, what if Mianserin had higher affinity for a2a which was more predominantly expressed on NE neurons compared to mirtazapine which might have lower (relative to Mianserin) affinity for a2a and higher affinity for a2c which could be expressed more so on serotonergic neurons? Just conjecture though.
And I can't recall where I remembered that study from, was probably searching for more about the a2 autoreceptors.